United Therapeutics | Koszty Operacyjne



Operating Expenses Zmiana Data
Amarin USD 67.47M 549K 2024-09
Ardelyx USD 108M 12M 2024-12
Baxter International USD 3.19B 644M 2024-12
Bayer EUR 8.2B 5.59B 2024-12
Biogen USD 2.01B 13.3M 2024-12
BioMarin Pharmaceutical USD 585.91M 45.94M 2024-12
Gilead Sciences USD 4.43B 687M 2025-03
GlaxoSmithKline GBP 5.3B 2.12B 2025-03
Halozyme Therapeutics USD 122.51M 4.38M 2024-12
Insmed USD 334.86M 28M 2024-12
Ionis Pharmaceuticals USD 278M 59.4M 2025-03
J&J USD 8.26B 10.37B 2025-03
Moderna USD 1.16B 1.06B 2025-03
Pfizer USD 10.05B 8.12B 2025-03
PTC Therapeutics USD 275.66M 24.36M 2024-12
Regeneron Pharmaceuticals USD 2.44B 362M 2025-03
Sarepta Therapeutics USD 496.73M 51.76M 2024-12
Teva Pharmaceutical Industries USD 3.77B 609M 2024-12
United Therapeutics USD 411.6M 33.4M 2025-03
Vertex Pharmaceuticals USD 1.89B 230.4M 2024-12



United Therapeutics Koszty Operacyjne - Aktualne wartości, dane historyczne, prognozy, statystyki, wykresy i kalendarz ekonomiczny - May 2025.